Professional Documents
Culture Documents
Nghiên C U Thăm Dò T NG H P Propacetamol Hydroclorid PDF
Nghiên C U Thăm Dò T NG H P Propacetamol Hydroclorid PDF
Nghiên C U Thăm Dò T NG H P Propacetamol Hydroclorid PDF
TRNG I HC DC H NI
NG VN THNG
H NI 2013
B Y T
TRNG I HC DC H NI
NG VN THNG
H NI 2013
LI CM N
Vi tt c lng knh trng, u tin ti xin by t lng cm n chn thnh v
su sc nht ti DS. Nguyn Vn Giang cng vi PGS.TS. Nguyn nh Luyn
ch nhim b mn Cng nghip Dc Trng i hc Dc H Ni, tn tnh
hng dn gip ti trong sut thi gian qua.
Cm n DS. Phm Th Hin, CN. Phan Tin Thnh cng cc bn ang lm
thc nghim ti Phng Tng hp Ha dc gip ti tm ti liu, ch dn thao
tc thc nghim gip ti trong sut qu trnh lm ti ti B mn.
Ti cng xin cm n cc thy c b mn Cng nghip Dc cng cc thy
c trong Trng i hc Dc H Ni du dt ti trong 5 nm va qua.
Cui cng ti xin cm n gia nh v bn b lun gip , khch l ti
trong thi gian qua.
H Ni, ngy 21 thng 05 nm 2013.
Sinh vin
Ng Vn Thng
MC LC
Trang
T VN .................................................................................................. 1
CHNG 1: TNG QUAN........................................................................... 2
1.1. Tng quan v propacetamol hydroclorid ............................................. 2
1.1.1. Cng thc cu to, cng thc phn t.................................................... 2
1.1.2. Tnh cht l ha ...................................................................................... 2
1.1.3. Cc phng php nh tnh, nh lng theo BP 2010 .......................... 3
1.1.4. Dc ng hc, c ch tc dng, tc dng v cng dng ..................... 3
1.1.5. u v nhc im khi s dng propacetamol........................................ 5
1.2. i nt v tin thuc (prodrug).............................................................. 5
1.2.1. Khi nim................................................................................................ 6
1.2.2. Mc ch ca tin thuc.......................................................................... 6
1.2.2.1. Tin thuc ci thin thm qua mng/kh nng vn chuyn qua
mng .................................................................................................... 6
1.2.2.2. Tin thuc ko di tc dng ................................................................. 7
1.2.2.3. Tin thuc lm thay i tan trong nc.......................................... 8
1.2.2.4. Tin thuc lm tng bn ha hc, gim chuyn ha ...................... 9
1.2.2.5. Tin thuc a thuc n ch tc dng ....................................... 10
1.2.2.6. Tin thuc lm gim c tnh v tc dng ph ................................. 10
1.2.2.7. Tin thuc ci thin mi v ................................................................ 10
1.3. Phng php tng hp propacetamol hydroclorid t paracetamol 11
1.3.1. Tng hp tc nhn acyl ha monocloroacetyl clorid .......................... 11
1.3.2. Cc phng php tng hp propacetamol hydroclorid vi tc nhn acyl
ha-monocloroacetyl clorid. ............................................................... 11
CHNG 2: I TNG, NI DUNG V PHNG PHP NGHIN
CU........................................................................................ 16
DANH MC CH VIT TT
BP 2010
DEA
: Diethylamin
DMSO
: Dimethyl sunfoxid
Gly
: Glycin
IR
MP
: Methylpresnisolon
MS
PAPC
: p-acetamidophenyl monocloroacetat
Rf
: H s lu gi (retension factor)
tonc
TEA
: Triethylamin
THF
: Tetrahydrofuran
TLC
H-NMR
magnetic resonance)
DANH MC CC BNG
Trang
Bng 2.1
16
Bng 2.2
17
Bng 3.1
22
Bng 3.2
26
Bng 3.3
30
Bng 3.4
31
Bng 3.5
31
Bng 3.6
Bng 3.7
32
33
Bng 3.8
33
Bng 3.9
34
DANH MC CC HNH V
Trang
Hnh 1.1
Hnh 1.2
C ch tc dng ca levodopa
Hnh 1.3
Hnh 1.4
Hnh 1.5
Hnh 1.6
Hnh 1.7
Hnh 1.8
Hnh 1.9
Hnh 1.10
10
Hnh 1.11
10
Hnh 1.12
11
Hnh 3.1
21
Hnh 3.2
22
Hnh 3.4
27
Hnh 3.3
28
DANH MC CC S
Trang
S 1.1
S 1.2
S 1.3
11
S 1.4
12
S 1.5
13
S 1.6
14
S 1.7
14
S 1.8
14
S 1.9
15
S 3.1
20
S 3.2
20
S 3.3
23
S 3.4
23
S 3.5
25
S 3.6
26
S 3.7
27
S 3.8
29
S 3.9
C ch phn ng acyl ha
35
36
S 3.11 C ch xc tc ca KI
36
T VN
Cng vi s pht trin ca x hi hin nay th m hnh bnh tt cng ngy
cng tr nn phc tp. Khi m ngi dn ang ngy cng s dng thuc nhiu hn
th i cng vi n l nguy c v tc dng ph v c tnh ca thuc ngy cng tng
cao.
Thit k tin thuc ang l mt trong lnh vc thu ht c nhiu s quan
tm ca cc nh tng hp ha dc trong v ngoi nc. Vic thay i cc thng s
vt l, ha l s gip tng hiu qu iu tr ng thi gim tc dng ph v c tnh
ca thuc.
Trn th gii hin nay, paracetamol l thuc gim au, h st ang c
dng rt ph bin do thuc an ton, hiu qu v dung np tt [20]. Trong nhng
trng hp cp tnh, bnh nhn hn m, chn thng nng hoc phu thutthuc
tim paracetamol s l la chn cho cc bc s gim nhanh chng cc triu chng
trn. Nhng do t tan v d b thy phn trong nc nn paracetamol gp rt nhiu
hn ch trong vic bo ch di dng thuc tim.
Chnh v nhng nhc im nh vy, tin thuc propacetamol hydrochlorid
c iu ch v a vo s dng rt rng ri di dng bt pha tim p ng
nhu cu s dng ngy cng a dng ca x hi.
Vi vai tr to ln ca propacetamol hydroclorid trong thc t iu tr do
chng ti thc hin ti Nghin cu thm d tng hp propacetamol
hydroclorid vi mc tiu sau:
Nghin cu xy dng, tng hp propacetamol hydroclorid quy m phng
th nghim.
KLPT: 300,8 vC
H: 6,99%
Cl: 11,81%
N: 9,32%
O: 15.97%
Phc mu hng
Chng ch nh
Tuyt i
- Mn cm vi propacetamol v cc thnh phn ca thuc, c bit l N,Ndiethylglycin do thuc gii phng [11].
- Nghi ng c d ng vi propacetamol, nht l nhng nhn vin y t tip xc vi
thuc c xut hin d ng [10].
- Suy t bo gan.
Tng i
- C thai 3 thng u [7, 8].
Ch phng v thn trng
- c bo co xut hin eczema cc nhn vin y t sau khi pha ch thuc tim
ny, do vy cn phi eo gng tay khi pha thuc hoc s dng h thng bm ht
thuc.
- Khng ngi c tin s eczema thao tc pha thuc, tip xc vi thuc [10].
1.1.5. u v nhc im khi s dng propacetamol
u im:
- Tc dng nhanh mnh, kim sot c nng trong mu hn so vi cc ng
dng khc, thun tin cho bc s khi cn gim au nhanh.
- n nh v mt ha hc, khng b nh hng bi cc t dc so vi thuc tim
paracetamol.
Nhc im:
Ngoi cc tc dng khng mong mun ca paracetamol, cn c thm mt s
nhc im khc ca thuc nh:
- Gy d ng cc nhn vin y t khi pha ch thuc tim tip xc vi
propacetamol [10].
- Tc dng ph khc: chng mt, au bng, bun nn, tng huyt p 15 pht ngay
sau khi tim, au ti ch tim [20,8,16].
1.2. i nt v tin thuc (prodrug)
Enalaprilat
Enalapril
L-aminoacid thm
decarboxylase no
H vn chuyn tch cc
(Hng ro mu no)
L-aminoacid
Ngoi vi
L-aminoacid thm
decarboxylase ngoi vi
Bacampicillin
Ampicillin
Azathioprin
6-mercaptopurin
Albendazol
Albendazol sunfoxid
Carbamazepin
N-gly-carbamazepin
Dexamethason
Paracetamol
Propacetamol hydroclorid
Ampicillin
Hectacillin
10
Trong hetacillin nhm amin c kha ngn cn s tn cng vo vng lactam dn n m vng ny v lm mt hot tnh ca ampicillin. Vo c th
hetacillin phn hy dn dn gii phng ampicillin v aceton.
1.2.2.5. Tin thuc a thuc n ch tc dng
Tin thuc loi ny thng c thit k bng cch to phc hp vi mt cht
mang ph hp. Cht mang c hp thu chn lc bi t bo hay vi sinh vt gy
bnh.
VD: Mepredex l mt tin thuc ca methylprenisolon c thit k a
thuc chn lc n i trng dng iu tr vim i trng mn tnh.
Carbecitabin
5-fluorouracil
11
Cloramphenicol (v ng)
S :
12
13
14
15
Gi thnh t.
Qua vic tham kho cc ti liu trn chng ti thy c nhng nhc
16
Tn thit b/ dng c
Xut s
Buchi Thy S
Cn k thut XB 320
Precisa Thy S
n soi UV sc k CN6
Vilber Lourmart c
Buchi Thy S
Eutech M
T hotte Unilab
Model TH 1300
10
11
17
Ph hng ngoi IR c ghi trn my Impact-410 Micolet ti Vin Ha hcVin Hn lm v Khoa hc Cng ngh vit Nam.
Ha cht:
Bng 2.2. Nguyn liu dung mi c s dng trong kha lun
Tn ha cht v thuc th
Ngun gc
Aceton
Trung Quc
Acid sulfuric c
Trung Quc
Anhydrid acetic
Merck- c
Diclomethan
Trung Quc
Diethylamin
Trung Quc
Ethanol 96%
Vit Nam
Kali carbonat
Trung Quc
Methanol
Trung Quc
Monocloro acetylclorid
Trung quc
Natri clorid
Trung Quc
Nc ct
Vit Nam
Paracetamol
Vit Nam
Tetrahydrofuran
Trung Quc
Triethylamin
Merck- c
18
19
20
S :
Tin hnh:
un hi lu hn hp gm 10,0g acid monocloroacetic (0,11mol) v 12,0ml
Tin hnh:
Ha tan 6,0g paracetamol (0,04mol) trong 10ml THF, thm 4,8ml pyridin (0,06
21
tonc: 183-185oC.
22
Nhit
Hiu sut
1:2
0-5oC
40,20%
1:2,5
0-5oC
55,34%
1:3
0-5oC
55,06%
1:3,5
0-5oC
54,87%
paracetamol: monocloroacetic
60%
Hiu sut
50%
40%
30%
20%
10%
0%
1/2
1/2,5
1/3
1/3,5
T l mol
23
Tin hnh:
Ha tan hon ton 6,0g paracetamol (0,04mol) trong 60ml aceton sau thm
tonc= 183-185oC.
Rf = 0,56.
Nhn xt: Vi xc tc K2CO3/aceton quy trnh phn ng d dng hn nhng thu
Tin hnh:
24
Ha tan 6,0g paracetamol (0,04mol) bng dung dch 16ml NaOH 10%, lm lnh
5-10oC, sau nh t t 20ml acetic monocloroacetic anhydrid iu ch trn
vo hn hp, khuy u lun duy tr iu kin lnh. Dng dung dch NaOH 10%
iu chnh pH t 7-8, khuy lin tc trong 4-5h. Lc, ra ta bng nc lnh n
pH trung tnh, sy kh, tinh ch bng ethanol 96%.
Kt qu:
-
tonc= 183-185oC.
Rf = 0,56.
Nhn xt:
Phn ng thu c vi hiu sut thp c th do:
25
Ha tan
Pyridin
THF
Paracetamol
Lm lnh
0-5oC
Ct loi
acid acetic
Acyl ha
Khuy 4-5h
Hi lu 138-140oC
3-4h
Rt t t
vo nc
Anhydrid acetic
Acid monocloroacetat
Nc ci
Lc
Nc ra
Ra ta
Ethanol 96%
Tinh ch
Ethanol 96%
PAPC
26
3.1.3. Giai on 3
Tng hp propacetamol base.
Phng trnh phn ng
Tin hnh:
Ha tan 10,0g PAPC (0,044mol) vo 100ml aceton un hi lu nhit 45-
50oC, sau thm 15,1g K2CO3 khuy lin tc K2CO3 phn tn u, thm tip
0,5g KI, khuy trong 30 pht. Sau nh t t 11,75ml DEA (0,11mol) t l
PAPC: DEA= 1: 2,5 vo hn hp, sau khi nh xong tip tc khuy thm 2h nhit
50oC. Khi kt thc phn ng, ngui, lc thu ly dch, sau ct quay dch
60oC n kit loi aceton v DEA d, thu c propacetamol dng du mu nu
.
Kt qu:
-
Hiu sut
1:2
45-50oC
60,20%
1:2,5
40-50oC
67,5%
1:3
45-50oC
67,34%
1:3,5
45-50oC
67,1%
27
70%
68%
Hiu sut
66%
64%
62%
60%
58%
56%
1/2
1/2,5
1/3
1/3,5
T l mol
S :
H2SO4(c)
Na2SO4
2HCl
28
Tin hnh: Hon tan hon ton 10g propacetamol base ( c tng hp giai
on 3) trong aceton, thm t t HCl/aceton vo khuy lin tc n khi pH=2 th
dng li tip tc khuy trong 30 pht cho phn ng hon ton, ra ta bng aceton,
sy kh 45-50oC.
Kt qu:
-
tonc: 223-225oC,
29
Ha tan 40 C
PAPC
Aceton
K2CO3
KI
Khuy u
30 pht
Nh t t
DEA
Khuy u 2-3h
DEA
Aceton
Ct loi dung mi
Propacetamol
dng base
Ha tan
trong aceton
Acid ha to
mui
HCl/aceton
Lc, ra ta
Tinh ch
Methanol
Sn phm
S 3.8. Quy trnh tng hp propacetamol hydroclorid
30
TLC c tin hnh trn bn mng trng sn silicagel GF254 70-230 mesh, quan
st di n t ngoi bc sng 254nm.
Rf
tonc (oC)
Paracetamol
0,1
167-169oC
PAPC
0,56
183-185oC
0,22
223-225oC
Propaceamol
hydroclorid
Nhn xt:
-
31
Cng thc
PAPC
max(cm-1)
Nhm
3272 v 3215
N-H (-CONH-)
3060
2961
C-H (-CH3)
2812
C-H (-CH2-)
1765
C=O (-COO-)
1665
C=O (-CONH-)
1554 v 1517
1208
C-O-C (ester)
717
C-Cl
Cng thc cu to
m/z
225,9 [M-H]-
32
Cng thc cu to
33
Cng thc cu to
max
Nhm
-1
(cm )
3235
N-H (-CONH-)
3130
2947
C-H (-CH3)
Propacetamol
2576
C-H (-CH2-)
hydroclorid
1767
C=O (-COO-)
1682
C=O (-CONH-)
1503
1196
C-O-C (ester)
Cng thc cu to
m/z
Propacetamol
base
263 [M-H]-
M=264,34
Nhn xt: T d liu bng trn c th nhn thy ph c pic phn t vi s
khi ng bng khi lng phn t tnh theo cng thc d kin.
34
Cng thc cu to
35
3.4. Bn lun
- Phn ng acyl ha to PAPC vi tc nhn anhydrid acid hn tp
Vi tc nhn l anhydrid hn tp th nhm acyl no hot ha mnh hn s th
vo phn t cn acyl ha.
Phn ng gia anhydrid acid hn tp v paracetamol, c ch phn ng xy ra nh
sau:
36
S phn ng:
Amin bc 3
Mui amoni
bc 4
S 3.11. C ch xc tc ca KI
Vi dung mi l aceton th cn phi ha tan ha ton PAPC 40-45oC do PAPC
t tan v trnh thy phn PAPC, sau mi cho thm K2CO3 v KI vo, khuy 30
pht KI hot ha cho phn ng.
Nhit phn ng khong: 45-50oC trnh thy phn PAPC.
Thi gian hi lu khong 2h l phn ng ht vi PAPC.
Sau phn ng cn ct quay dch di p sut gim loi ht aceton v DEA khi
acid ha khng c c tp mui clorid ca DEA.
- Qu trnh acid ha to propacetamol
37
38
KT LUN V XUT
- Kt lun
Trong qu trnh thc hin kha lun ny chng ti thu c mt s kt qu
nh sau:
1. Tng hp thnh cng propacetamol hydroclorid t paracetamol
Khng nh c cu trc ca cc cht trung gian v sn phm tng hp
bng phng php phn tch ph IR, MS, 1H-MNR.
nh gi s b tinh khit ca propacetamol bng TLC v o nhit
nng chy.
2. Kho st nh hng ca cc xc tc n hiu sut qu trnh phn ng.
Kho st nh hng ca K2CO3/aceton; dung dch NaOH 10% n hiu sut
tng hp PAPC.
Kho st nh hng ca t l mol n hiu sut tng hp ca PAPC v
propacetamol.
- xut
1. Nghin cu kho st thm cc yu t, ti u ha quy trnh lm tng hiu sut ca
qu trnh tng hp propacetamol.
2. Kim nghim propacetamol t BP 2010 v trin khai tng hp quy m pilot.
1.
2.
3.
4.
5.
6.
7.
8.
Phm Thip, V Ngc Thy (2004), Thuc bit dc & cch s dng,
Nh xut bn Y Hc, H Ni, tr. 783.
9.
Ting Anh.
10.
11.
12.
13.
14.
Depr M., Hecken A., Verbesselt R., et al. (1992), "Tolerance and
pharmacokinetics of propacetamol, a paracetamol formulation for
intravenous use", Fundamental & clinical pharmacology, 6(6), pp. 259262.
15.
16.
17.
18.
19.
20.
McNicol E. D., Tzortzopoulou A., Cepeda M. S., et al. (2011), "Singledose intravenous paracetamol or propacetamol for prevention or
treatment of postoperative pain: a systematic review and metaanalysis", British journal of anaesthesia, 106(6), pp. 764-775.
21.
22.
23.
24.
25.
Viel E., Langlade A., Osman M., et al. (1999), Propacetamol: from
basic action to clinical utilization, Annales francaises d'anesthesie et de
reanimation,pp. 332.
Ting Trung.
26.
, , (2007), "",
pp. 75-76.
PH LC
Ph lc 1: Ph hng ngoi IR ca PAPC
Ph lc 2: Ph khi lng MS ca PAPC
Ph lc 3: Ph cng hng t proton 1H-NMR ca PAPC
Ph lc 4: Ph cng hng t proton 1H-NMR ca PAPC (m rng)
Ph lc 5: Ph hng ngoi IR ca propacetamol hydroclorid
Ph lc 6: Ph khi lng MS ca propacetamol base
Ph lc 7: Ph cng hng t proton 1H-NMR ca propacetamol hydroclorid
Ph lc 8: Ph cng hng t proton 1H-NMR ca propacetamol hydroclorid (m
rng)
M=227,64
M= 264,34